ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3138

Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis

Giacomo De Luca1, Silvia Laura Bosello1, Francesca Gabrielli2, Giorgia Berardi1, Federico parisi1, Manuela Rucco1, Giovanni Canestrari1, Leonarda Galiuto3, Filippo Crea3, Francesco Loperfido2 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Division of Heart Failure and Cardiac Rehabilitation, Catholic University - Rome, Rome, Italy, 3Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, heart disease and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Heart involvement is common during Systemic Sclerosis (SSc), even if often clinically silent, and represents the leading cause of death in about one third of patients. Arrhythmias, in particular, are a frequent event and portend a bad prognosis, accounting alone for 6% of SSc total deaths. We performed a prospective cohort study to define the role of 24h-ECG-Holter in the identification of patients at high risk of life-threatening arrhythmias and sudden cardiac death(SCD) in Systemic Sclerosis.

Methods:

100 SSc-patients with symptoms and/or signs suggestive of cardiac involvement underwent 24h-ECG-Holter. The primary end-point was a composite of SCD or the need for implantable cardioverter defibrillator(ICD). A mean follow-up of 23.1±16.0 months was reached.

Results:

Fifty-six patients(56%) had 24h-ECG-Holter alterations and 24(24%) presented frequent ventricular ectopic beats(VEBs), classified as polymorphic in 11 (26.2%). The mean number of VEBs was strikingly high (2046.1 ± 6027.8//24h), with a maximum of 33615/24h. Supraventricular ectopic beats (SVEBs)>1000/24h were also frequent (19%), with a mean number of 798.9±1835.6 per day; seventeen patients (17%) presented runs of SVEBs. Fourteen patients (14%) presented episodes of supraventricular paroxysmal tachycardia (SVPT), with a maximum of 36 beats, while 11 patients (11%) exhibited runs of NS-VT, the longest of 34 beats. The number of VEBs correlated with cardiac troponin T(cTnT) levels (R=0.4,p<0.001) and inversely correlated with left ventricular ejection fraction(LV-EF) on echocardiography (R=-0.4,p<0.001). Furthermore, the number of VEBs directly correlated with severity index and with the extension of skin involvement evaluated by the mRSS (p=0.3 for both correlations).

During the follow-up, 5 patients died of SCD and two required ICD-implantation for life-threatening arrhythmias. The 7 patients who met the composite end-point had a higher number of VEBs, higher levels of cTnT and NT-proBNP and lower LV-EF(p=0.001 for all correlations), while in all of them a pulmonary arterial hypertension was ruled out by right heart catheterization. All 7 patients had frequent ventricular ectopy at baseline ECG-Holter, while LV-EF range in patients who met the primary end-point was wide and LV-EF was not reduced in all. At ROC curve, VEBs>1190/24h showed 100% of sensitivity and 83% of specificity to predict the primary end-point (AUROC=0.92,p<0.0001). Patients with VEBS>1190/24h had lower LV-EF and higher cTnT levels compared to patients with VEBs<1190/24h.

Conclusion:

VEBs are frequent in SSc and correlate with cardiac damage; VEBS>1190/24h identify patients at high risk of major arrhythmic complications. 24h-ECG-Holter need to be considered as a part of routine evaluation in SSc-patients with suspicious cardiac involvement and it could be an additional risk-stratification technique for selection of SSc-patients at high-risk of SCD, in whom an ICD-implantation could represent a potential life-saving intervention.


Disclosure: G. De Luca, None; S. L. Bosello, None; F. Gabrielli, None; G. Berardi, None; F. parisi, None; M. Rucco, None; G. Canestrari, None; L. Galiuto, None; F. Crea, None; F. Loperfido, None; G. Ferraccioli, None.

To cite this abstract in AMA style:

De Luca G, Bosello SL, Gabrielli F, Berardi G, parisi F, Rucco M, Canestrari G, Galiuto L, Crea F, Loperfido F, Ferraccioli G. Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/prognostic-role-of-ventricular-ectopic-beats-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prognostic-role-of-ventricular-ectopic-beats-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology